지혈 밸브 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Hemostasis Valves Market size is expected to reach USD 355.16 Million in 2034 from USD 202.87 Million (2025) growing at a CAGR of 6.42% during 2026-2034.

The hemostasis valves market is expanding alongside rising interventional procedures and image-guided therapies where catheter-based access is routine. Hemostasis valves, which prevent blood loss while allowing instrument exchange, are essential for vascular, cardiology, and interventional radiology suites. Growth is propelled by increasing cardiovascular disease prevalence, aging populations, and higher procedural volumes for minimally invasive interventions. Clinicians value valves that improve workflow, reduce blood exposure risk, and integrate with a range of sheath sizes.

Product innovation-miniaturized designs, improved seal materials, and compatibility with high-flow catheters-is an important market driver. Hospitals seek valves that reduce procedural time and consumable costs while complying with sterility standards. Expansion of outpatient interventional centers and ambulatory surgical settings supports adoption of single-use, sterile hemostasis devices. Training and procedural standardization also increase utilization, as teams adopt validated tools that simplify catheter exchanges and reduce complications.

Looking forward, demand should continue as interventional cardiology and endovascular oncology procedures rise. New valve materials and combination devices (valve plus introducer) will improve ease of use. Growth opportunities include emerging markets where minimally invasive procedural capacity is scaling and outpatient interventional services are expanding. Manufacturers that offer breadth of sizes and validated clinical data will gain competitive advantage.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Hemostasis Valve Y- Connectors
• Double Y- Connector Hemostasis Valves
• One- Handed Hemostasis Valves
• Others

By Application

• Angiography
• Angioplasty

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Boston Scientific Corporation, Teleflex Incorporated, Merit Medical Systems, B Braun Melsungen AG, Terumo Corporation, Abbott, Argon Medical Devices, Freudenberg Medical, SCW Medicath Ltd, Lepu Medical TechnologyBeijingCo Ltd, Nipro, DeRoyal Industries Inc, Antmed Corporation, Beijing Demax Medical Technology Co
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMOSTASIS VALVES MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Hemostasis Valve Y- Connectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Double Y- Connector Hemostasis Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. One- Handed Hemostasis Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMOSTASIS VALVES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Angiography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Angioplasty Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMOSTASIS VALVES MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEMOSTASIS VALVES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEMOSTASIS VALVES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Boston Scientific Corporation
  • 9.2.2 Teleflex Incorporated
  • 9.2.3 Merit Medical Systems
  • 9.2.4 B. Braun Melsungen AG
  • 9.2.5 Terumo Corporation
  • 9.2.6 Abbott
  • 9.2.7 Argon Medical Devices
  • 9.2.8 Freudenberg Medical
  • 9.2.9 SCW Medicath Ltd
  • 9.2.10 Lepu Medical Technology(Beijing)Co. Ltd
  • 9.2.11 Nipro
  • 9.2.12 DeRoyal Industries Inc
  • 9.2.13 Antmed Corporation
  • 9.2.14 Beijing Demax Medical Technology Co